Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the full study content with a minimal header/footer; this indicates the page is inaccessible, limiting visibility into the trial information and attachments.
    Difference
    18%
    Check dated 2026-09-20T22:57:08.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now includes posted results with metrics such as Complete Response rate, Overall Response Rate, and 2-year Progression-Free Survival, along with the posting dates and a PDF of the Study Protocol and Statistical Analysis Plan. Older results-submission entries, including the complete response rate, have been removed.
    Difference
    2%
    Check dated 2026-09-06T22:26:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.5 to v3.6.6, indicating a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-08-30T22:19:20.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Page revision was updated from v3.6.4 to v3.6.5, signaling a software release or maintenance update to the ClinicalTrials.gov page. The update does not modify study details, eligibility criteria, or other content visible on the page.
    Difference
    0.1%
    Check dated 2026-08-09T11:04:30.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Results have been submitted for this study record, replacing the previous 'No Results Posted' status. The page revision has been updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T23:11:21.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Milestone dates for the study were updated to reflect revised timelines, including the primary completion date and the estimated study completion. The date of the most recent update was added.
    Difference
    0.3%
    Check dated 2026-07-11T16:59:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.